Contraception · Adverse Effects
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users
Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP, Cooper WO
Cite this paper
Sidney, S., Cheetham, T. C., Connell, F. A., Ouellet-Hellstrom, R., Graham, D. J., Davis, D., Sorel, M., Quesenberry, C. P., & Cooper, W. O. (2013). Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception, 87(1), 93-100. https://doi.org/10.1016/j.contraception.2012.09.015
Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP, Cooper WO. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013;87(1):93-100. doi:10.1016/j.contraception.2012.09.015
Sidney, Stephen, et al. "Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users." Contraception, vol. 87, no. 1, 2013, pp. 93-100.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.


